The most effective treatment for pancreatic cancer depends on the stage of the cancer and the patient's overall health. Surgery is the primary treatment for pancreatic cancer, including Whipple surgery and Distal surgery, but it is only possible if the cancer has not spread beyond the pancreas. At present, some new surgical techniques and instruments, such as minimally invasive surgery, robotic surgery and 3D printing technology, are also widely used in the treatment of pancreatic cancer to improve the effect of surgery and the survival rate of patients. Chemotherapy and radiation therapy may also be used to treat pancreatic cancer, either alone or in combination with surgery. In recent years, new chemotherapeutic drugs, such as Navumab and Paclitaxel, have been widely used in the treatment of pancreatic cancer, which can significantly improve the efficacy of chemotherapy and the survival rate of patients. Targeted therapy refers to the use of drugs targeting tumor targets, such as epidermal growth factor receptor inhibitors and vascular endothelial growth factor receptor inhibitors, to inhibit tumor growth and spread. Targeted therapy can significantly improve the efficacy and survival rate of patients with pancreatic cancer. Immunotherapy refers to the use of the strength of the patient's own immune system to attack cancer cells, such as immune checkpoint inhibitors, CAR-T cell therapy and so on. Immunotherapy can enhance the immunity of patients, improve the efficacy of pancreatic cancer and the survival rate of patients. Pancreatic cancer is a serious disease that can cause severe symptoms and can be difficult to treat. It is important to see a doctor if you experience any symptoms, as early detection can improve the chances of successful treatment.